Copyright
©2013 Baishideng Publishing Group Co.
World J Pharmacol. Dec 9, 2013; 2(4): 107-114
Published online Dec 9, 2013. doi: 10.5497/wjp.v2.i4.107
Published online Dec 9, 2013. doi: 10.5497/wjp.v2.i4.107
Cell type | AhR-dependent effect | Ref. |
Th | Absence of AhR increases secretion of inflammatory cytokines (IFN-γ, IL-12) | [71] |
Treg | Activation of AhR by TCDD increases their proliferation | [58] |
Tr1 | IL-27-induces AhR activity, which in combinatio with c-Maf, suppresses their differentiation | [72] |
B cells | TCDD enhances IgM secretion and inhibits the differentiation of plasma cells | [73] |
DCs | TCDD reduces the number of splenic DCs | [74] |
Macrophage | AhR-STAT1 interactions suppress the activation and differentiation of macrophage, and induces the IgA receptor FcαRI. TCDD reduces CD11a expression. | [49,75] [76] |
- Citation: Vega L, Elizondo G. Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders. World J Pharmacol 2013; 2(4): 107-114
- URL: https://www.wjgnet.com/2220-3192/full/v2/i4/107.htm
- DOI: https://dx.doi.org/10.5497/wjp.v2.i4.107